DYN — Dyne Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates DYN Bullish with a Setup Score of 43, net conviction 45, actionability 42. How the Setup Score works →

Total Setup Score43
Directional BiasBullish
Net Conviction45
Actionability42 (in range)

Key signals behind this score

About Dyne Therapeutics Inc

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases usin… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$26.34
Market Cap$4.85B
Float186.3M
Shares Outstanding186.7M
vs. Analyst Target+49.6% to analyst PT
Dividend RateNone
Analyst Target Price$39.40 (14 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$58.7M -$700,000 -$57.9M
2021 N/A -$149M -$1.1M -$148M
2022 N/A -$165M -$3.3M -$169M
2023 N/A -$236M -$2.5M -$233M
2024 N/A -$317M -$2.2M -$315M
2025 N/A -$446M -$2.0M -$438M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 N/A -$108M
Dec 2025 N/A -$112M
Mar 2026 N/A -$121M
Jun 2026 N/A -$179M

Ownership & Float

Insider Ownership0.2%
Institutional Ownership103.7%
Short Float11.8%
% of All Funds Holding2.81%
Number of Funds Holding247

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$24.52Near-term / short-term trend
Weekly40-Week SMA$19.65Medium-term trend
Weekly80-Week SMA$16.19Cyclical trend (business cycle)
Weekly200-Week SMA$18.41Secular trend (multi-year)
Monthly10-Month SMA$20.37Near-term monthly trend
Monthly20-Month SMA$16.69Medium-term monthly trend
Monthly40-Month SMA$19.98Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$14.80 support 1.04x 4 months ago
$12.70 support 1.17x 9 months ago
$9.70 support 1.36x 11 months ago

Historical Earnings Reactions (25 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.60% -0.11% 44.00% 8.16% -2.39%
1 Day -0.29% 0.31% 52.00% 16.37% -12.89%
1 Week -3.03% -3.59% 44.00% 27.73% -36.46%
2 Weeks -2.74% -1.63% 48.00% 41.39% -29.59%
1 Month -2.05% -6.89% 37.50% 53.01% -46.24%

Next earnings: October 17, 2026 (52 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.16% 44.1% 279
Tuesday -0.08% 49.0% 308
Wednesday 0.59% 53.3% 306
Thursday -0.07% 46.3% 298
Friday 0.02% 47.0% 298

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 103.7%

Insider Transactions — Smart Summary

Total insider ownership: 0.2%

12-Month Insider Activity Summary

Total Filings45
Net Value-$809,119.927
Net Shares Change-7,592,288
% of Float-4.1%
C-Suite Filings22
Clusters Detected7

Key Insiders

NameTitleNet ValueFilingsActivity
Rhodes Jason P -$83.0M 2 N/A
Posner Brian S +$274,840 7 7 buy
Lucera Erick Chief Financial Officer -$48,113.94 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-09-08 – 2025-09-09 3 3 -$108,038.677 3 C-suite
2025-12-05 – 2025-12-05 3 3 -$76,373.92 3 C-suite
2026-03-06 – 2026-03-13 7 5 -$15.7M 3 C-suite
2026-05-06 – 2026-05-14 5 5 -$2.1M 4 C-suite
2026-06-09 – 2026-06-22 5 5 -$1.7M 3 C-suite
2026-06-24 – 2026-07-08 5 3 -$39.7M 1 C-suite
2026-08-17 – 2026-08-17 5 5 -$65.4M 4 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-06-05 Posner Brian S +$43,700 Transaction at $17.48, now +50.7%
2026-05-28 Posner Brian S +$36,420 Transaction at $18.21, now +44.6%
2026-06-09 Posner Brian S +$33,880 Transaction at $16.94, now +55.5%
2026-06-26 Lucera Erick Chief Financial Officer -$48,113.94 Transaction at $20.37, now +29.3%
2026-05-22 Posner Brian S +$42,800 Transaction at $17.12, now +53.9%
2026-04-01 Posner Brian S +$34,160 Transaction at $17.08, now +54.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Dyne Therapeutics Inc (DYN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for DYN on Trend Edge →